The Neuropathic Joint

Floyd, Waldo E.; Lovell, Woodrow W.; Re, King

doi:10.1097/00007611-195905000-00012

Cited by 26 publications

(7 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…J.K. Mitchell from Philadelphia had described twelve cases of "arthritis" in 1831 related to spinal cord lesions [13], and two years later reported 35 more patients with similar pathologies [14]. Charcot duly acknowledged Mitchell's earlier reports [15]. However, there is considerable controversy as to whether Mitchell's reports were truly due to neuropathic arthritis [16,17].…”

Section: Historymentioning

confidence: 99%

Charcot neuroarthropathy in diabetes mellitus

et al. 2002

View full text Add to dashboard Cite

Charcot neuroarthropathy has been recognised for over 130 years and yet it remains a major cause of morbidity for patients with diabetes mellitus and a continuing challenge for physicians. It is rare but it seems to be increasing in prevalence and this provides hope that with larger studies it will soon be possible to clarify the natural history and optimal treatment regimens. The underlying cause is thought to be trauma in a neuropathic foot that leads to a complex series of pathological processes culminating in bone and joint destruction and subsequent deformity. The acute reaction is often misdiagnosed and many patients present late with established deformity. Even when the diagnosis is considered at an early stage there are no definitive criteria or tests to confirm charcot neuroarthropathy and a high index of suspicion is necessary in any diabetic patient with a swollen warm foot in the presence of somatic or autonomic neuropathy. Treatment has traditionally involved the use of various methods to avoid weight bearing but recent work has begun to suggest that bisphosphonates might be able to arrest the acute process. In the long term, treatment involves a multidisciplinary approach aimed at providing appropriate footwear to reduce plantar pressures and avoid foot ulceration; in some circumstances this involves surgical correction of deformities before adequate footwear can be supplied. Further studies of the emerging treatments for Charcot neuroarthropathy are needed to provide long-term outcome data on morbidity and deformity.

show abstract

Section: Historymentioning

confidence: 99%

Charcot neuroarthropathy in diabetes mellitus

et al. 2002

View full text Add to dashboard Cite

show abstract

“…Among the patients with neuropathic arthropathy, the elbow joint is thought to be affected in only 3% to 8% of cases. 3,5 Most publications, similar to this report, are case studies with a limited number of patients. In addition, there is no information in the literature regarding the surgical treatment for this entity.…”

Section: Discussionmentioning

confidence: 55%

“…The most common of these nervous disorders is diabetic neuropathy of the lower extremity, and as such, neuropathic arthropathy has been most extensively described in the joints of the ankle and the foot. 2,3,5,7,12,14 Other diseases that are also associated with neuropathic arthropathy include poliomyelitis and syringomyelia. 2,6,7 Neuropathic arthropathy in the elbow joint is extremely rare, with limited information in the literature.…”

mentioning

confidence: 99%

Neuropathic elbow arthropathy: A review of six cases

Kwon

Morrey

2006

Journal of Shoulder and Elbow Surgery

View full text Add to dashboard Cite

“…4 Disease progression brings about the destruction of the shoulder joint and is often complicated with neurologic manifestations caused by syringomyelia in the cervical spine. 7 Charcot shoulder is thought to originate from neurologic mechanisms, but this is still in debate.…”

mentioning

confidence: 99%